Kallo has put
together an advanced suite of medical technology offerings that vastly improve
quality and efficiency of healthcare delivery, with products ranging from
health informatics solutions like !ntegraat, which integrates with existing
medical technologies and allows for the seamless transmission of data off any
EMR, PACS, HIS, RIS, PIS or DI-r device, to fully-equipped and
telehealth-enabled mobile clinic solutions like MobileCare™, designed to bring
the latest, best-in-class medical equipment to remote and unreached
communities. The company’s RuralCare™, pre-fabricated, project determined
modular solutions, ranging in size from 1.2k to 3.8k square feet, are intended
for rapid implementation (as little as one week) of response capability in
rural areas or locations hit by a disaster. An ingenious concept capable of
bringing the complete architecture of a clinic to bear when and where it is
needed, with everything from x-ray and ultrasound machines, to surgical
operating rooms, a laboratory, and even a pharmacy.
With total global
health expenditure now somewhere over $6.5T according to WHO data (9.3% of GDP
on average globally, or 17.7% here in the states during 2011), KALO stands
poised to deliver full-spectrum medical technology solutions into an eager
market, solutions that are reinforced by cutting edge data and information handling
capabilities. The company cuts a rather wide swath in the industry already,
addressing critical healthcare and business needs of both healthcare
organizations, hospitals, physicians, and Ministries of Health, but the real
long-term upside is largely still ahead of KALO and interested investors could
really make a killing here while helping to save and enhance lives.
The growing $25B
medical tourism industry has been fueled by globalization and reduced costs of
travel, as well as mounting pressures on local/regional healthcare systems that
produce inordinate wait times for patients or poor quality of care. This
revenue-rich market is perfect for solutions like KALO’s CygnaMed™ platform,
which enables Ministries of Tourism and Health to promote medical tourism in
their country, all within a fully bi-directional software environment that
allows for circumspect standardization of clinical processes, as well as
constantly evolving/varied protocols for treatment. Such a solution allows for
optimum care continuity irrespective of location and the software platform also
allows providers to easily make sense of differing pharmacopeia (pharmaceutical
drug preparation specs), helping to ameliorate the growing concern over
iatrogenic effects linked to patient medications.
The company recently
inked a major supply and maintenance contract with the Minister of Health and
Public Hygiene of Guinea valued at over $200M for MobileCare and RuralCare
deployments in Guinea, with a sweeping public awareness campaign already afoot
and emphasis on the rural areas. This is a huge move backed firmly by the
President of Guinea himself, Professor Condé, who has made it a priority to get
the kind of top-notch healthcare KALO can provide, rapidly out to the people of
Guinea. This is the kind of bottom-line driving deal that KALO was created to
seize hold of and investors should take note at the underserved global
healthcare market (especially in massively underserved regions like Guinea) and
the traction possible for the company’s innovative drop-in, full-spectrum
healthcare solutions.
The company’s
critical medical data integration and dissemination platform Keristaa™ has come
into sharper focus recently with the continued spread of the MERS virus in
Saudi Arabia and the first U.S. case also having cropping up here in the last
few days. Keristaa enables instantaneous monitoring of outbreaks of infectious
disease, detecting and indentifying port of entry vulnerabilities and
channeling the data directly to relevant CDC and Ministry of Health offices,
further maintaining a strict protocol envelope for treatment that is in line
with CDC/WHO directives. The May 3 announcement by the Guinea Ministry of
Health regarding some 231 suspected and confirmed cases, as well as 155 deaths
from the incredibly dangerous Ebola hemorrhagic fever across the country
(including in the capital of Conakry), brings into stark contrast the need for
such platforms as Keristaa, as well as its efficacy in helping to thwart
pandemics. Moreover, it throws a spotlight on the aggressive move by the Guinea
government to roll out serious healthcare infrastructure via KALO and the
company’s key role in helping to avert a more serious global problem, as the
virus has already spread to neighboring Liberia.
KALO’s commitment to
developing their far-reaching presence in this space is further reinforced by
their oHealth framework, which brings together the requisite technology and
training, as well as infrastructure and support, to allow for seamless
integration between any kind of clinic, lab or other specialty medical facility,
with full leveraging of and communication with any repository or
national/regional Health Information Access Layers. The company’s intuitive
approach to addressing rising global healthcare demands spells shareholder gold
and investors will want to keep an eye on KALO as the company continues to
outpace antiquated healthcare implementation models in the still-emerging,
developing nations in particular.
More info on Kallo
is available at www.KalloInc.ca
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment